Sandip Prasad, MD, discusses patient selection for chemoablation in recurrent LG-IR-NMIBC and considerations when counseling patients about a nonsurgical approach.
|Videos|February 10, 2020
LUGPA President Dr. Richard Harris: 2020 challenges
LUGPA President Dr. Harris discusses legislative/policy challenges in 2020.
Advertisement
LUGPA President Dr. Harris discusses legislative/policy challenges in 2020. Urology Times spoke with Dr. Harris at the 2019 LUGPA annual meeting in Chicago.
Related content
Advertisement
Related to this article
The AACU and the WOCN Society urge CMS to protect access to individualized catheter and ostomy supplies as competitive bidding begins in 2028.
Eugene Cone, MD, discusses recombinant BCG for NMIBC, including ongoing clinical evaluation and its potential to address ongoing BCG supply challenges.
Eugene Cone, MD, discusses SWOG S1602 findings comparing Tokyo-172 and TICE BCG and the potential role of alternative BCG strains in NMIBC
Juan Gómez-Rivas, MD, discusses barriers to PSMA-PET imaging and how disparities in access may affect prostate cancer staging and treatment planning.
Jonathan Harper, MD, discusses findings from the PUSH trial may inform counseling on hydration and stone recurrence.
Cameron C. Jones, MD, discusses patient selection for Aquablation, including prostate size, anatomy, and factors that may favor alternative BPH procedures.
Andrew Peterson, MD, discusses the quality-of-life impact of post-cancer incontinence and advances in electronically controlled artificial urinary sphincters.
Advertisement
Advertisement
Trending on Urology Times
1
The Evolving Landscape of Minimally Invasive BPH Therapy
2
TURP, HoLEP, and the Future of Minimally Invasive BPH Therapy
3
FDA grants 510(k) clearance to SpaceOAR Flex Hydrogel for prostate radiotherapy
4
One year of Inlexzo: Evolving care in BCG-unresponsive NMIBC
5